Pathstone Family Office’s ARK Genomic Revolution ETF ARKG Stock Holding History

Pathstone Family Office’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$489K	Buy	+17,557	New	+$574K	﹤0.01%	1048
2023 Q1	–	Sell	-32,114	Closed	-$1.19M	–	1220
2022 Q4	$1.19M	Buy	32,114 +2,938	+10%	+$93.2K	0.01%	704
2022 Q3	$960K	Buy	29,176 +14,487	+99%	+$532K	0.01%	762
2022 Q2	$463K	Buy	14,689 +191	+1%	+$6.68K	0.01%	610
2022 Q1	$665K	Sell	14,498 -97	-0.7%	-$4.63K	0.02%	445
2021 Q4	$895K	Hold	14,595	–	–	0.02%	363
2021 Q3	$1.09M	Hold	14,595	–	–	0.03%	271
2021 Q2	$1.35M	Buy	14,595 +215	+1%	+$18.3K	0.04%	211
2021 Q1	$1.28M	Buy	+14,380	New	+$1.43M	0.04%	178

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Pathstone Family Office's ARKG Position: Q3 2023 in Review

Pathstone Family Office opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2023: 17,557 shares worth $489K. The stake represents ﹤0.01% of the portfolio and ranks #1048 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in ARKG as recently as Q4 2022.

Pathstone Family Office first reported a position in ARKG in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.35M in Q2 2021. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Pathstone Family Office held 17,557 shares of ARK Genomic Revolution ETF worth $489K as of Q3 2023.
ARK Genomic Revolution ETF was a new Pathstone Family Office position in Q3 2023.
ARK Genomic Revolution ETF made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1048 holding.
Pathstone Family Office first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 9 quarters since.
Pathstone Family Office's ARK Genomic Revolution ETF position peaked at $1.35M in Q2 2021.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.